These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4543621)

  • 1. Identification and toxicological effects of dehydroretronecine, a metabolite of monocrotaline.
    Hsu IC; Allen JR; Chesney CF
    Proc Soc Exp Biol Med; 1973 Dec; 144(3):834-8. PubMed ID: 4543621
    [No Abstract]   [Full Text] [Related]  

  • 2. Dehydroretronecine-induced rhabdomyosarcomas in rats.
    Allen JR; Hsu IC; Carstens LA
    Cancer Res; 1975 Apr; 35(4):997-1002. PubMed ID: 1116156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoplastic transformation in tissues of rats exposed to monocrotaline or dehydroretronecine.
    Shumaker RC; Robertson KA; Hsu IC; Allen JR
    J Natl Cancer Inst; 1976 Apr; 56(4):787-90. PubMed ID: 176409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroretronecine-induced skin tumors in mice.
    Johnson WD; Robertson KA; Pounds JG; Allen JR
    J Natl Cancer Inst; 1978 Jul; 61(1):85-9. PubMed ID: 276619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver.
    Mattocks AR; Croswell S; Jukes R; Huxtable RJ
    Toxicon; 1991; 29(4-5):409-15. PubMed ID: 1907409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids.
    Mattocks AR; Jukes R; Brown J
    Toxicon; 1989; 27(5):561-7. PubMed ID: 2749755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine-conjugated pyrrole identified in rat urine following administration of two pyrrolizidine alkaloids, monocrotaline and senecionine.
    Estep JE; Lamé MW; Jones AD; Segall HJ
    Toxicol Lett; 1990 Nov; 54(1):61-9. PubMed ID: 2123045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of monocrotaline, a pyrrolizidine alkaloid, on regenerating rat liver.
    Chesney CF; Allen JR; Hsu I
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):859-62. PubMed ID: 4701274
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline.
    Lamé MW; Morin D; Jones AD; Segall HJ; Wilson DW
    Toxicol Lett; 1990 May; 51(3):321-9. PubMed ID: 2111054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimitotic effects of dehydroretronecine pyrrole.
    Allen JR; Hsu IC
    Proc Soc Exp Biol Med; 1974 Nov; 147(2):546-50. PubMed ID: 4548195
    [No Abstract]   [Full Text] [Related]  

  • 12. Trapping of short-lived electrophilic metabolites of pyrrolizidine alkaloids escaping from perfused rat liver.
    Mattocks AR; Legg RF; Jukes R
    Toxicol Lett; 1990 Nov; 54(1):93-9. PubMed ID: 2244344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimitotic activity of dehydroretronecine, a pyrrolizidine alkaloid metabolite, and some analogous compounds, in a rat liver parenchymal cell line.
    Mattocks AR; Legg RF
    Chem Biol Interact; 1980 Jun; 30(3):325-36. PubMed ID: 7379211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of sulphur-conjugated pyrrolic metabolites in blood and fresh or fixed liver tissue from rats given a variety of toxic pyrrolizidine alkaloids.
    Mattocks AR; Jukes R
    Toxicol Lett; 1992 Oct; 63(1):47-55. PubMed ID: 1412522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Lafranconi WM; Ohkuma S; Huxtable RJ
    Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ¹H NMR study of monocrotaline and its metabolites in human blood.
    Yang YC; Crowder J; Wardle NJ; Yang L; White KN; Wang ZT; Annie Bligh SW
    Food Chem Toxicol; 2011 Nov; 49(11):2793-9. PubMed ID: 21843583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):58-63. PubMed ID: 8048054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum copper concentration in monocrotaline pyrrole treated rats with pulmonary hypertension.
    Ganey PE; Roth RA
    Biochem Pharmacol; 1987 Oct; 36(20):3535-7. PubMed ID: 3675611
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoplasia and chronic disease associated with the prolonged administration of dehydroheliotridine to rats.
    Peterson JE; Jago MV; Reddy JK; Jarrett RG
    J Natl Cancer Inst; 1983 Feb; 70(2):381-6. PubMed ID: 6571945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.